First AI-generated drug enters human clinical trials, targeting chronic lung disease patients
The first-ever drug generated by artificial intelligence has entered Phase 2 clinical trials, with the first dose successfully administered to a human, Insilico Medicine announced yesterday. The drug, currently referred to as...